Patents by Inventor Zemin Lin

Zemin Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240406530
    Abstract: A .camera lens protector assembly of mobile phone includes multiple eye members and a protector cover which is manufactured by a method including a sandblasting step, a hole forming step, an oxidizing step and a cutting step form a starting material of an integral cover sheet. The protector cover has multiple through holes for mounting one or more eye members, so as to protect the camera lenses of the mobile phone, and the protector cover comprises an outer surface which has a surface profile formed from a processing surface of the integral cover sheet.
    Type: Application
    Filed: June 5, 2023
    Publication date: December 5, 2024
    Inventor: Zemin Lin
  • Patent number: 11045475
    Abstract: Provided in the present invention is a use of methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate in the preparation of a medicament for treating psoriasis and vitiligo. More specifically, the present invention uses mice whose psoriasis is induced by an imiquimod cream to observe a changing condition in skin lesions on the psoriasis-like mice, according to a psoriasis skin lesion area of the mice and grading standards for disease severity; the present invention also observes a proportion of lymphocytes in the spleens and cytokines in skin lesion tissues of the mice. A good therapeutic effect may be obtained by treating typical cases of vitiligo with an ointment of methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate. Results show that methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate used in the present invention has a good therapeutic effect on psoriasis and vitiligo, as well as a favorable prospect in clinical application.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: June 29, 2021
    Assignees: SHANGHAI INST. OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES, NINGBO ZIYUAN PHARMACEUTICALS INC.
    Inventors: Jianping Zuo, Wei Tang, Zemin Lin, Chongsheng Yuan
  • Publication number: 20200030284
    Abstract: The present invention provides a use of artemisinin derivatives, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment or adjuvant treatment of inflammatory bowel disease. In an animal model of inflammatory bowel disease induced by dextran sulfate sodium (DSS), the experimental results of the artemisinin derivative, or the pharmaceutically acceptable salt thereof, of the present invention showed that oral gavage administration can effectively alleviate colitis symptoms of IBD mice such as weight loss, diarrhea, and hematochezia, reduce pathological damage in colon tissue, inhibit the infiltration of inflammatory cells in colon tissue of IBD mice, and downregulate levels of disease-related proinflammatory cytokines.
    Type: Application
    Filed: March 26, 2018
    Publication date: January 30, 2020
    Inventors: Jianping ZUO, Wei TANG, Yuxi YAN, Ping Ll, Shijun HE, Zemin LIN, Xiaoqian YANG, Chunlan FENG, Fenghua ZHU
  • Publication number: 20190216817
    Abstract: Provided in the present invention is a use of methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate in the preparation of a medicament for treating psoriasis and vitiligo. More specifically, the present invention uses mice whose psoriasis is induced by an imiquimod cream to observe a changing condition in skin lesions on the psoriasis-like mice, according to a psoriasis skin lesion area of the mice and grading standards for disease severity; the present invention also observes a proportion of lymphocytes in the spleens and cytokines in skin lesion tissues of the mice. A good therapeutic effect may be obtained by treating typical cases of vitiligo with an ointment of methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate. Results show that methyl 4-[9-(6-aminopuryl)]-2(s)-hydroxybutyrate used in the present invention has a good therapeutic effect on psoriasis and vitiligo, as well as a favorable prospect in clinical application.
    Type: Application
    Filed: June 29, 2017
    Publication date: July 18, 2019
    Inventors: Jianping ZUO, Wei TANG, Zemin LIN, Chongsheng YUAN
  • Publication number: 20120211130
    Abstract: A high-elongation rate aluminum alloy material and preparation method thereof. The high-elongation aluminum alloy material contains, in weight percentage, 0.30-1.20% of iron, 0.03-0.10% of silicon, 0.01-0.30% of rare earth elements, namely cerium and lanthanum, and the remaining aluminum and inevitable impurities. The aluminum alloy is made from materials through a fusion casting process and a half-annealing treatment. An aluminum alloy conductor made thereof has a high-elongation rate and good safety and stability in use.
    Type: Application
    Filed: April 9, 2010
    Publication date: August 23, 2012
    Inventors: Zemin Lin, Lehua Yu, Youmei Wan
  • Patent number: D1056657
    Type: Grant
    Filed: September 12, 2024
    Date of Patent: January 7, 2025
    Assignee: Shenzhen Yingeer Technology Co., LTD
    Inventor: Zemin Lin
  • Patent number: D1062435
    Type: Grant
    Filed: September 15, 2024
    Date of Patent: February 18, 2025
    Assignee: Shenzhen Yingeer Technology Co., LTD
    Inventor: Zemin Lin
  • Patent number: D1066706
    Type: Grant
    Filed: August 12, 2022
    Date of Patent: March 11, 2025
    Assignee: Jiangsu Yishun Medical Equipment Co., Ltd.
    Inventors: Zhi Zhang, Zemin Lin